PARADOXICAL FACILITATION OF PENTYLENETETRAZOLE-INDUCED CONVULSION SUSCEPTIBILITY IN MICE LACKING NEURONAL NITRIC OXIDE SYNTHASE

被引:53
作者
Itoh, K. [1 ,2 ]
Watanabe, M. [1 ]
机构
[1] Tokushima Bunri Univ, Lab Brain Sci, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan
[2] Tokushima Bunri Univ, Mol & Cellular Neurosci Lab, Kagawa Sch Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan
关键词
nNOS inhibitors; kindling; generalized epilepsy model; ionotropic glutamate receptor knockout mice; CENTRAL-NERVOUS-SYSTEM; INDUCED SEIZURES; L-ARGININE; RECEPTOR ANTAGONISTS; KINDLING MODEL; RAT-BRAIN; EPILEPSY; ANTICONVULSANT; GLUTAMATE; CALMODULIN;
D O I
10.1016/j.neuroscience.2008.12.040
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The major aim of this study was to elucidate the relationship between nitric oxide (NO) and generalized epilepsy. Mice lacking the neuronal nitric oxide synthase (nNOS) gene (nNOS(-/-)) were used in this study to determine the relationship between nNOS a and NO in pentylentetrazole (PTZ)-induced convulsions. nNOS(-/-) mice exhibited severe convulsions following injection with a subconvulsive dose of PTZ (40 mg/kg i.p.) and convulsive doses were lethal in all of the mice (60 mg/kg i.p.) following tonic convulsions. The results were confirmed by using selective nNOS inhibitors in wild-type (nNOS(+/+)) mice. The higher doses of the nNOS inhibitors 1-[2-(trifluoromethyl)phenyl] imidazole (TRIM) and 3-bromo-7-nitroindazole (3Br7NI) inhibited clonic-tonic convulsions induced by a convulsive dose of PTZ (60 mg/kg) in nNOS(+/+) mice. In contrast, either TRIM or 3Br7NI at lower doses enhanced convulsions following injection with a subconvulsive dose of PTZ (40 mg/kg) in nNOS(+/+) mice similar to nNOS(-/-) mice treated with PTZ. Such a proconvulsant effect was observed in nNOS(+/+) mice pretreated with nNOS inhibitors but not other NOS inhibitors. These results indicate that NO may be regarded as an anticonvulsant or a proconvulsant substance in relation to convulsions induced by PTZ in mice. Pretreatment with N-methyl-D-aspartate (NMDA) receptor antagonists (5S, 10R)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5,10-imine maleate (MK-801), (E)-(+/-)-2-amino-4-methyl-5-phospho no-3-pentenoic acid ethyl ester, CGP39551) and DL-alpha-amino3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist (2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo-[f]quinoxaline-7-sulfonamide, NBQX) inhibited a subconvulsive dose of PTZ-induced convulsions in nNOS(-/-) mice, demonstrating that convulsions induced by PTZ are modulated by endogenous NO production and ionotropic glutamate receptor-mediated stimulation. These results suggest a negative or positive modulation of neuronal interactions by basal or enhanced NO production, respectively. (C) 2009 IBRO. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:735 / 743
页数:9
相关论文
共 39 条
[1]   Atypical neural messengers [J].
Barañano, DE ;
Ferris, CD ;
Snyder, SH .
TRENDS IN NEUROSCIENCES, 2001, 24 (02) :99-106
[2]   Nitric oxide content measured by ESR-spectroscopy in the rat brain is increased during pentylenetetrazole-induced seizures [J].
Bashkatova, V ;
Vitskova, G ;
Narkevich, V ;
Vanin, A ;
Mikoyan, V ;
Rayevsky, K .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2000, 14 (03) :183-190
[3]   NITRIC-OXIDE MEDIATES GLUTAMATE-LINKED ENHANCEMENT OF CGMP LEVELS IN THE CEREBELLUM [J].
BREDT, DS ;
SNYDER, SH .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (22) :9030-9033
[4]  
Chapman A G, 1996, Epilepsy Res Suppl, V12, P239
[5]   Glutamate receptors in epilepsy [J].
Chapman, AG .
GLUTAMATE SYNAPSE AS A THERAPEUTICAL TARGET: MOLECULAR ORGANIZATION AND PATHOLOGY OF THE GLUTAMATE SYNAPSE, 1998, 116 :371-383
[6]   Molecular basis of NMDA receptor-coupled ion channel modulation by S-nitrosylation [J].
Choi, YB ;
Tenneti, L ;
Le, DA ;
Ortiz, J ;
Bai, G ;
Chen, HSV ;
Lipton, SA .
NATURE NEUROSCIENCE, 2000, 3 (01) :15-21
[7]   Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats [J].
De Sarro, G ;
Di Paola, ED ;
Gareri, P ;
Gallelli, L ;
Scotto, G ;
De Sarro, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 368 (2-3) :149-159
[8]  
de Vasconcelos AP, 2000, EPILEPSIA, V41, P363
[9]  
DESARRO GB, 1991, FUNDAM CLIN PHARM, V5, P503
[10]  
DURING MJ, 1993, LANCET, V341, P1607